Home General Biotechnology Drug Patent Expirations in October 2012

Drug Patent Expirations in October 2012

Drug Patent Expirations for October 2012

TradenameApplicantGeneric NamePatent NumberPatent Expiration
AZOPTAlcon Pharms Ltdbrinzolamide5,378,703*PEDOct 1, 2012
RAPAMUNEWyeth Pharms Incsirolimus5,403,833*PEDOct 4, 2012
TRITECGlaxosmithklineranitidine bismuth citrate5,456,925Oct 10, 2012
ALOMIDEAlconlodoxamide tromethamine5,457,126Oct 10, 2012
SPRIXLuitpoldketorolac tromethamine7,476,689Oct 11, 2012
ZEMPLARAbbvieparicalcitol5,246,925*PEDOct 17, 2012
OXANDRINSavient Pharmsoxandrolone6,670,351Oct 20, 2012
STARLIXNovartisnateglinide5,463,116Oct 21, 2012
CLARITIN-D 24 HOURSchering Ploughloratadine; pseudoephedrine sulfate5,314,697Oct 23, 2012
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.